NCT06344507 Iconographic Registry of Pancreatobiliary Endoscopy Procedures
| NCT ID | NCT06344507 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS San Raffaele |
| Condition | Pancreas Neoplasm |
| Study Type | OBSERVATIONAL |
| Enrollment | 12,000 participants |
| Start Date | 2022-03-28 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 12,000 participants in total. It began in 2022-03-28 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the TAILOR-EUS study (Iconographic Registry of Bilio-Pancreatic Endoscopic Ultrasound Procedures) is to establish a clinical registry comprising images and videos generated during endoscopic procedures conducted for the investigation of pancreatic diseases (PD). The study will compile historical, pathological, and imaging data from approximately 12,000 patients (2,000 retrospectively and 10,000 prospectively) who underwent endoscopic ultrasound procedures for inflammatory pancreatic conditions (e.g., acute, recurrent, chronic pancreatitis), autoimmune bilio-pancreatic diseases (e.g., autoimmune pancreatitis), neoplastic bilio-pancreatic conditions, and screenings for individuals at high risk of developing such diseases at the Bilio-Pancreatic Endoscopy and Endoscopic Ultrasound Unit of the IRCCS San Raffaele Hospital between 2000 and 2027. Participants have undergone or will undergo the standard diagnostic pathway appropriate for their conditions as part of routine clinical practice. All instrumental examinations and endoscopic ultrasound procedures are integral to the standard diagnostic and therapeutic approach for pancreatic diseases.
Eligibility Criteria
Inclusion Criteria: * Suspected or confirmed diagnosis of inflammatory pancreatic disease (e.g., acute, recurrent, or chronic pancreatitis) or autoimmune bilio-pancreatic disease (e.g., autoimmune pancreatitis) or bilio-pancreatic neoplastic disease, necessitating an endoscopic ultrasonography procedure. * Age over 18 years. * Ability to provide informed consent. Exclusion Criteria: * Pregnancy and breastfeeding status. * Contraindications to the endoscopic ultrasonography procedure
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06344507 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreas Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06344507 currently recruiting?
Yes, NCT06344507 is actively recruiting participants. Contact the research team at tacelli.matteo@hsr.it for enrollment information.
Where is the NCT06344507 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06344507 clinical trial?
NCT06344507 is sponsored by IRCCS San Raffaele. The trial plans to enroll 12,000 participants.